Renin-angiotensin system blockade to prevent preeclampsia in a rodent model of diabetic nephropathy
Year: 2018
Type: dissertation
Abstract: Diabetic women with diabetic nephropathy (DN) or albuminuria will have to stop angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II type 1 receptor blockers (ARB) treatments during pregnancy, since those drugs have fetotoxic effects. However, it is unclear if they must be discontinued months before pregnancy or when pregnancy is confirmed. Indeed, earlier discontinuation of ACEIs is associated with the progression of DN and an increased risk of pre-eclampsia (PE). The objective this project was to assess the benefits on mother’s health of ACEI discontinuation at pregnancy confirmation in comparison of an earlier discontinuation. Streptozotocin have been used to induced diabetes in a rat model and lisinopril (an ACEI) and insulin treatments have been started after four weeks of hyperglycemia. ACEI treatment has been discontinued three weeks before or at pregnancy confirmation and a PE has been induced with reduced uterine perfusion pressure (RUPP) surgery on day 14 of gestation. Euthanasia of animals was on day 19 of gestation. There was no difference between diabetic rats for arterial pressure, neither for proteinuria, expression of type IV collagen, TGF-, podocin and nephrin (podocyte markers), mesangium expansion and glomerular hypertrophy, those being all renal function markers. These results suggest that DN did not developed in our model, impeding a proper comparison between the two different groups of ACEI treatment. However, renal weight was higher in diabetic group and a diminution in podocytes number was observed in diabetic group without ACEI, suggesting incipient renal pathology and protective effect of ACEI on podocyte shedding. Among groups with RUPP surgery, arterial pressure was elevated, endotheliosis was observed, as well as a diminution of weight and survival of pups. These results suggest our RUPP model is functional. To answer the project’s hypothesis, optimization of the protocol is necessary to have development of ND in our groups.
Author: Lavoie Marilou
Institution: Université de Sherbrooke
Language: French
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Fonds de recherche du Québec
OpenAlex ID: W7201933289
